European Medical Solutions (FRA:AS0) EV-to-EBIT : -153.07 (As of Jun. 18, 2024)

View and export this data going back to 2021. Start your Free Trial

What is European Medical Solutions EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, European Medical Solutions's Enterprise Value is €42.55 Mil. European Medical Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.28 Mil. Therefore, European Medical Solutions's EV-to-EBIT for today is -153.07.

The historical rank and industry rank for European Medical Solutions's EV-to-EBIT or its related term are showing as below:

FRA:AS0' s EV-to-EBIT Range Over the Past 10 Years
Min: -383.43 Med: -5.75 Max: 1.64
Current: -153.07

During the past 12 years, the highest EV-to-EBIT of European Medical Solutions was 1.64. The lowest was -383.43. And the median was -5.75.

FRA:AS0's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 9.37 vs FRA:AS0: -153.07

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. European Medical Solutions's Enterprise Value for the quarter that ended in Dec. 2023 was €40.32 Mil. European Medical Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.28 Mil. European Medical Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.69%.

European Medical Solutions EV-to-EBIT Historical Data

The historical data trend for European Medical Solutions's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Medical Solutions EV-to-EBIT Chart

European Medical Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.52

-8.50

-361.90

-17.38

-171.83

European Medical Solutions Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-361.90	-	-17.38	-	-171.83

Competitive Comparison of European Medical Solutions's EV-to-EBIT

For the Biotechnology subindustry, European Medical Solutions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Medical Solutions's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, European Medical Solutions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where European Medical Solutions's EV-to-EBIT falls into.

European Medical Solutions EV-to-EBIT Calculation

European Medical Solutions's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	42.554	/	-0.278
	=	-153.07

European Medical Solutions's current Enterprise Value is €42.55 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. European Medical Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.28 Mil.

European Medical Solutions (FRA:AS0) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

European Medical Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.278	/	40.319785
	=	-0.69 %

European Medical Solutions's Enterprise Value for the quarter that ended in Dec. 2023 was €40.32 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. European Medical Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.28 Mil.

European Medical Solutions EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of European Medical Solutions's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

European Medical Solutions (FRA:AS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » European Medical Solutions (FRA:AS0) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ALIMG:Belgium

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

European Medical Solutions (FRA:AS0) Headlines

No Headlines